Your browser doesn't support javascript.
loading
Machine Learning Methods in Health Economics and Outcomes Research-The PALISADE Checklist: A Good Practices Report of an ISPOR Task Force.
Padula, William V; Kreif, Noemi; Vanness, David J; Adamson, Blythe; Rueda, Juan-David; Felizzi, Federico; Jonsson, Pall; IJzerman, Maarten J; Butte, Atul; Crown, William.
Afiliação
  • Padula WV; Department of Pharmaceutical and Health Economics, School of Pharmacy, University of Southern California, Los Angeles, CA, USA; The Leonard D. Schaeffer Center for Health Policy & Economics, University of Southern California, Los Angeles, CA, USA. Electronic address: padula@usc.edu.
  • Kreif N; Centre for Health Economics, University of York, York, England, UK.
  • Vanness DJ; Department of Health Policy and Administration, College of Health and Human Development, Pennsylvania State University, Hershey, PA, USA.
  • Adamson B; Flatiron Health, New York, NY, USA.
  • Rueda JD; AstraZeneca, Cambridge, England, UK.
  • Felizzi F; Novartis, Basel, Switzerland.
  • Jonsson P; National Institute for Health and Care Excellence, Manchester, England, UK.
  • IJzerman MJ; Centre for Health Policy, School of Population and Global Health, University of Melbourne, Melbourne, Australia.
  • Butte A; School of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Crown W; The Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USA. Electronic address: wcrown@brandeis.edu.
Value Health ; 25(7): 1063-1080, 2022 07.
Article em En | MEDLINE | ID: mdl-35779937
ABSTRACT
Advances in machine learning (ML) and artificial intelligence offer tremendous potential benefits to patients. Predictive analytics using ML are already widely used in healthcare operations and care delivery, but how can ML be used for health economics and outcomes research (HEOR)? To answer this question, ISPOR established an emerging good practices task force for the application of ML in HEOR. The task force identified 5 methodological areas where ML could enhance HEOR (1) cohort selection, identifying samples with greater specificity with respect to inclusion criteria; (2) identification of independent predictors and covariates of health outcomes; (3) predictive analytics of health outcomes, including those that are high cost or life threatening; (4) causal inference through methods, such as targeted maximum likelihood estimation or double-debiased estimation-helping to produce reliable evidence more quickly; and (5) application of ML to the development of economic models to reduce structural, parameter, and sampling uncertainty in cost-effectiveness analysis. Overall, ML facilitates HEOR through the meaningful and efficient analysis of big data. Nevertheless, a lack of transparency on how ML methods deliver solutions to feature selection and predictive analytics, especially in unsupervised circumstances, increases risk to providers and other decision makers in using ML results. To examine whether ML offers a useful and transparent solution to healthcare analytics, the task force developed the PALISADE Checklist. It is a guide for balancing the many potential applications of ML with the need for transparency in methods development and findings.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inteligência Artificial / Lista de Checagem Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inteligência Artificial / Lista de Checagem Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article